Comparison of Topical and Intravenous Tranexamic Acid in Total Hip Arthroplasty
NCT02312440
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
173
Enrollment
OTHER
Sponsor class
Conditions
Blood Loss
Interventions
DRUG:
0.9% sodium chloride
DRUG:
tranexamic acid
DRUG:
tranexamic acid
Sponsor
Shanghai Jiao Tong University School of Medicine